Glaukos iStent: measures slightly larger than the width of a human hair

Glaukos iStent: measures slightly larger than the width of a human hair

Laguna Hills-based Glaukos Corp. has filed plans to raise $86 million in an initial public offering.

Glaukos makes the iStent, which is implanted in the eye to treat glaucoma, a major cause of blindness.

It plans to list its shares on the New York Stock Exchange.

The company’s investors include Versant Ventures, a venture capital firm that is based in Menlo Park and has an office in Newport Beach.